SAREPTA THERAPEUTICS INC

CUSIP: 803607AB6 Class: DBCV 1.500%11/1

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,000 Value ($000) $2 Avg Close Range
Q2 2024
Shares 117,000 Value ($000) $251 Avg Close Range
Q1 2024
Shares 52,000 Value ($000) $93 Avg Close Range
Q4 2023
Shares 2,000 Value ($000) $3 Avg Close Range
Q3 2023
Shares 2,000 Value ($000) $4 Avg Close Range
Q2 2023
Shares 152,000 Value ($000) $257 Avg Close Range
Q1 2023
Shares 5,000 Value ($000) $10 Avg Close Range
Q4 2022
Shares 2,000 Value ($000) $4 Avg Close Range
Q3 2022
Shares 3,388,000 Value ($000) $5,624 Avg Close Range
Q2 2022
Shares 1,254,000 Value ($000) $1,572 Avg Close Range
Q1 2022
Shares 1,361,000 Value ($000) $1,781 Avg Close Range
Q4 2021
Shares 3,341,000 Value ($000) $4,871 Avg Close Range
Q3 2021
Shares 3,396,000 Value ($000) $5,007 Avg Close Range
Q2 2021
Shares 6,076,000 Value ($000) $7,983 Avg Close Range
Q1 2021
Shares 6,526,000 Value ($000) $8,571 Avg Close Range
Q4 2020
Shares 3,000,000 Value ($000) $7,295 Avg Close Range
Q3 2020
Shares 2,938,000 Value ($000) $6,064 Avg Close Range
Q2 2020
Shares 2,329,000 Value ($000) $5,343 Avg Close Range
Q1 2020
Shares 6,350,000 Value ($000) $9,658 Avg Close Range
Q4 2019
Shares 2,164,000 Value ($000) $4,205 Avg Close Range
Q3 2019
Shares 3,081,000 Value ($000) $4,114 Avg Close Range
Q2 2019
Shares 2,100,000 Value ($000) $4,672 Avg Close Range
Q1 2019
Shares 1,745,000 Value ($000) $3,147 Avg Close Range